Deconstructing the Prescription Drug Supply Chain


With Americans concerned about the rising cost of health care, there is growing scrutiny on Capitol Hill of the various practices in the biopharmaceutical supply chain and how they contribute to costs. On May 3, 2018, POLITICO – in partnership with PhRMA – brought together leaders from across the biopharmaceutical supply chain for a conversation about what can be done to better control costs.


  • Gerard Anderson, Professor of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health
  • Anthony Barrueta, Senior Vice President, Government Relations, Kaiser Permanente
  • Kristin Bass, Senior Vice President, Policy and Federal Affairs, Pharmaceutical Care Management Association
  • Stacie Maass, Senior Vice President, Pharmacy Practice and Government Affairs, American Pharmacists Association
  • Ian Read, CEO, Pfizer
  • Angus Worthing, M.D., Partner, Arthritis & Rhumatism Associates PC; Clinical Assistant Prof., Georgetown University Medical Center


The Newseum, 8th Floor
555 Pennsylvania Avenue, NW
Washington, DC


Thursday, May 3, 2018
Doors open at 8:30 AM

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.